CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses
Research and development	$ 2,000	$ 1,375	$ 5,038	$ 3,296
General and administrative	970	896	3,319	2,984
Total operating expenses	2,970	2,271	8,357	6,280
Net operating loss	(2,970)	(2,271)	(8,357)	(6,280)
Other income
Interest income	2	29	25	70
Total other income	2	29	25	70
Net loss	$ (2,968)	$ (2,242)	$ (8,332)	$ (6,210)
Net loss per share, basic and diluted (in dollars)	$ (0.80)	$ (0.78)	$ (2.26)	$ (2.51)
Basic and diluted weighted average number of common shares outstanding	3,692	2,872	3,692	2,471